Regenxbio (RGNX) Stock Highlights

7.62 | +2.83%

2024-12-21 05:20:02

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).

Statistics

Range Today

7.21 7.75

Volume Today 10.68M

Range 1 Year

7.38 28.8

Volume 1 Year 168.97M

Range 3 Year

7.38 36.35

Volume 3 Year 370.28M

Range 10 Year

7.07 85.1

Volume 10 Year 979.36M

Highlights

Market Capitalization 552.92M (small)

Floating Shares 40.89M

Current Price 7.62

Price To Earnings -2.24

Price To Revenue 5.25

Price To Book 1.83

Earnings Per Share -5.01

Payout Ratio 0%

Performance

Latest +2.83%

1 Month -20.29%

3 Months -38.4%

6 Months -37.54%

1 Year -61.02%

3 Years -76.37%

5 Years -81.59%

10 Years -74.82%

Benchmarks

Market Capitalization

134 / 368

Gross Profits

262 / 278

Total Revenue

91 / 300

Total Rank

247 / 368

Free Cashflow

310 / 352

Performance 5 years

234 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.